发明授权
US07378409B2 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
有权
取代的环烷基胺衍生物作为趋化因子受体活性的调节剂
- 专利标题: Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
- 专利标题(中): 取代的环烷基胺衍生物作为趋化因子受体活性的调节剂
-
申请号: US10923538申请日: 2004-08-19
-
公开(公告)号: US07378409B2公开(公告)日: 2008-05-27
- 发明人: Percy H. Carter , Robert J. Cherney , Douglas G. Batt , Gregory D. Brown , John V. Duncia , Daniel S. Gardner , Michael G. Yang
- 申请人: Percy H. Carter , Robert J. Cherney , Douglas G. Batt , Gregory D. Brown , John V. Duncia , Daniel S. Gardner , Michael G. Yang
- 申请人地址: US NJ Princeton
- 专利权人: Bristol-Myers Squibb Company
- 当前专利权人: Bristol-Myers Squibb Company
- 当前专利权人地址: US NJ Princeton
- 代理商 Terence J. Bogie; Laurelee L. Duncan; Mary K. VanAtten
- 主分类号: A61K31/166
- IPC分类号: A61K31/166 ; C07D265/30 ; C07D487/04 ; C07D239/74 ; C07D239/26 ; C07D213/76 ; C07D231/12 ; C07D207/333 ; C07D205/04 ; C07D307/46
摘要:
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.